Parkinson’s Disease Market Expected to Reach $7 Billi…
On August 5, 2025, Clinical Trials Arena released a market forecast detailing significant growth in Parkinson’s disease (PD) therapeutics …
Read more
Drug Shortages Threaten Patient Safety in Africa
The U.S. Agency for International Development (USAID) is responsible for nearly 70% of American global health aid [9]. As a result, recent p…
Read more
The Future of RegTech in Medical Devices & SaMD: 8…
Emerging technologies like artificial intelligence, predictive analytics, and blockchain are redefining how medical devices and Software as …
Read more
Major U.S. Reform Bill Triggers Regulatory Consequences…
July 4, 2025 – In a move set to reshape key sectors, U.S. President Donald Trump has signed into law H.R.1 – the “One Big Beautiful Bi…
Read more
EMA Releases June 2025 PRAC Safety Updates for EU-Autho…
The European Medicines Agency (EMA) has released updated safety signal recommendations from its PRAC committee on June 2, 2025.This update r…
Read more
FDA Launches “Elsa”: Agency-Wide Generative…
On June 2, 2025, the U.S. Food and Drug Administration (FDA) officially launched Elsa, a generative artificial intelligence (AI) tool develo…
Read more
MAHA Commission Releases Report on U.S. Childhood Chron…
Presidential Commission Releases Landmark Report on U.S. Childhood Chronic Disease Crisis May 22, 2025 – The Presidential Commission to Ma…
Read more
HHS and FDA Request for Information: Identifying Unnece…
On May 13, 2025, the U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) issued a Request for…
Read more
JAMA Publishes Analysis of FDA and NIH Withdrawal of DE…
On April 11, 2025 the Journal of the American Medical Association (JAMA) has published a detailed analysis highlighting the potential cons…
Read more
US Department of Commerce Investigates Potential Tarif…
On April 4, 2025, Fierce Pharma published an article discussing the potential impact of President Donald Trump’s tariffs on the biopha…
Read more